A small pilot has seen some remarkable breakthroughs by using etanercept to treat patients who are suffering from Alzheimer's. Entanercept is a biological antagonist of TNF Alpha which Tobinick and Gross have evidence to suggest is centrally involved in the onset of AD symptoms. Description of their reasoning, study, and remarkable results can be found in the Journal of Neuroinflammation.
See Tobinick EL, Gross H. on PubMed
Citation:
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
J Neuroinflammation. 2008 Jan 9;5(1):2 [Epub ahead of print]
PMID: 18184433 [PubMed - as supplied by publisher]
